SAN JOSE, Calif.--(BUSINESS WIRE)-- Outset Medical, Inc. (Nasdaq: OM) (“Outset”) today announced that its Tablo® Hemodialysis System has received the first-ever approval from the Centers for Medicare ...

SAN JOSE, Calif.--(BUSINESS WIRE)--Fifty-seven year old dialysis patient Tracey Amadi of central New Jersey is the first person in the world to use Outset Medical’s mobile Tablo Hemodialysis System at ...

Please provide your email address to receive an email when new articles are posted on . ORLANDO — In this video from ASN Kidney Week, Michael Aragon, MD, the chief medical officer of Outset Medical, ...

Please provide your email address to receive an email when new articles are posted on . WASHINGTON — Data presented at ASN Kidney Week show Outset Medical’s Tablo hemodialysis system was safe and ...

Guam to receive HHS emergency deployment of Outset Medical’s mobile, easy-to-use dialysis technology for patients with kidney failure. “Tablo’s ease of use enables health care professionals, even ...

About a month and a half after pausing shipments of its Tablo hemodialysis system for at-home use, Outset Medical has secured the renewed FDA clearance it was waiting for, greenlighting new sales of ...

The home dialysis market is growing. Outset Medical's Tablo system has been deemed a substantial clinical improvement over current home dialysis units. With increasing revenues and a growing backlog, ...

Outset Medical continued to face a multivariate equation of headwinds last quarter. The stock has continued its long-term downtrend whilst technical indicators aren't signalling a reversal any time ...

Outset Medical announced a hold on shipments of its Tablo dialysis system to home users. This hold will be in place until the FDA completes its review of a new regulatory filing. Outset's revenue will ...